DTECT-ALL
Live / Registered — Registered (as of 17 Mar 2020)
What this means for you
Registered since 17 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88144649
- Registration number
- 6010862
- Mark type
- Stylized text
- Filed
- 05 Oct 2018
- Published for opposition
- 31 Dec 2019
- Registered
- 17 Mar 2020
- Attorney of record
- Jeffrey M. Goehring
Goods and services
- Class 001 — Chemicals: Chemical additives used in the biotechnology and pharmaceutical industries; Chemicals used for biotechnology industry; Chemicals used for biological purposes in the field of industry; biological preparations for use in biotechnological industry and science; Chemical reagents, other than for medical or veterinary purpose
- Class 005 — Pharmaceuticals: Chemical preparations used in the pharmaceutical industries for treating cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; Chemicals used for biological purposes in the medical field; Chemicals used in the medical and veterinary industries; biological preparations for use in the medical and veterinary industries for the treatment of cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; biological preparations for use in the pharmaceutical industry for medical treatment of cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; biological preparations for use in pharmaceuticals industry in the field of industry and science; Pharmaceutical and veterinary pharmaceutical preparations for treating cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical and veterinary use; medical or biological diagnostic tests for diagnosing cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; medical or biological diagnostic tests for the identification of molecules for treating cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases
- Class 009 — Scientific and electric apparatus: Scientific apparatus and instruments, for the measurement of biological, pharmacological, psychological or chemical phenomena, namely, for measuring interactions between chemicals, molecules, proteins, antibodies and peptides with their targets
- Class 042 — Scientific and technological services: Scientific research and development relating to molecules for therapeutic use; scientific research and development relating to new procedures and experiments for discovering, identifying or improving molecules for therapeutic use; scientific laboratory and engineering services for developing molecule for therapeutic use
Owner
- Domain Therapeutics, ILLKIRCH-GRAFFENSTADEN, FR
- Domain Therapeutics, ILLKIRCH-GRAFFENSTADEN, FR
- Domain Therapeutics, ILLKIRCH-GRAFFENSTADEN, FR
Prosecution history
- 17 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Mar 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Mar 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 23 Mar 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Mar 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 31 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2019 — PUBLISHED FOR OPPOSITION
- 11 Dec 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Nov 2019 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 19 Nov 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Nov 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Aug 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Nov 2019 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 21 Aug 2019 — TEAS POST PUBLICATION AMENDMENT RECEIVED